Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

Reliv International Inc. (RELV) ProVantage Athletic Performance Supplement Adds LunaRich Soy Powder, Earns U.S. Patent

|Includes: Reliv' International, Inc. (RELV)

Reliv International Inc. produces nutritional supplements that promote optimal nutrition in addition to premium skincare products. The company's supplements address essential nutrition, weight loss, digestive health, women's health, anti-aging and athletic performance. It sells its products through an international network of independent distributors in 15 countries.

The company made two announcements today. The first is that it has added LunaRich soy powder to its ProVantage athletic performance supplement, the fifth of its products to contain it. LunaRich is a company-exclusive whole soy powder containing five to ten times more lunasin than the industry standard. Lunasin is a peptide found naturally in soy that scientists have identified as the key to many of soy's documented health benefits. It is believed lunasin protects against and reduces oxidative stress and inflammation caused by high-impact exercise.

Studies have shown that soy is effective in promoting health and optimal fitness. ProVantage provides soy protein for increased muscle mass and function, maximizing the lunasin content to aid in muscle recovery and repair. And now it has a patent to back up its claims.

The second announcement made by Reliv is that ProVantage has earned a U.S. patent. This is the seventh of the company's products to receive a patent. The other six products are: Arthaffect for joint health, Cellebrate for weight loss, FibRestore for digestive health, Innergize for performance nutrition, GlucAffect for blood sugar management, and ReversAge for anti-aging nutrition. The patent on the company's essential daily nutrition product, Reliv Classic, has expired.

For additional information about Reliv International and its complete line of nutritional products, please visit the company's website at

Please see disclaimer on the MissionIR website